StockTipsArenaBeta

BUY Dr. Reddy's Laboratories Limited — Sumeet Bagadia, Choice Broking

BUYDr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories share price target & all analyst calls

bySumeet Bagadia, Choice BrokingHorizon: NA (inferred Intraday)15 Jul 2026, 8:51 am ISTvia Zee Business (Live)

Entry₹1,249.1Inferred
Target₹1,270
Total upside +1.67% (call closed)
Stop loss₹1,220-2.33% risk
At expiry₹1,23015 Jul 2026, 3:20 pm
Expired-1.53%
Follow Sumeet Bagadia for new calls(11% target hit, 71 closed calls)Get alertsWatch DRREDDY for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 26 Oct, 12:42 am IST
1 supporting2 neutral0 opposing
Supports the BUY call (1)

1 advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·9 Jul · 5d ago

Neutral / worth noting (2)

Dr. Reddy's Laboratories will release its Q1FY27 financial results on Wednesday, July 22nd, 2026. An earnings call is scheduled for the same day to discuss financial performance.

NSE · Press Release·13 Jul · 2d ago

(opens in new tab)

Dr. Reddy's Laboratories will announce its Q1FY27 financial results on Wednesday, July 22nd, 2026, followed by an earnings call at 19:30 PM IST.

BSE · Company Update·13 Jul · 2d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Dr. Reddy's Laboratories

All analyst calls on Dr. Reddy's Laboratories

More from Sumeet Bagadia, Choice Broking

Every call and its outcome